Literature DB >> 20400987

Long-term outcomes after hematopoietic SCT for adult T-cell leukemia/lymphoma: results of prospective trials.

I Choi1, R Tanosaki, N Uike, A Utsunomiya, M Tomonaga, M Harada, T Yamanaka, M Kannagi, J Okamura.   

Abstract

We have previously conducted clinical trials of allogeneic hematopoietic SCT with reduced-intensity conditioning regimen (RIC) for adult T-cell leukemia/lymphoma (ATLL)-a disease caused by human T-lymphotropic virus type 1 (HTLV-1) infection and having a dismal prognosis. Long-term follow-up studies of these trials revealed that 10 of the 29 patients have survived for a median of 82 months (range, 54-100 months) after RIC, indicating a possible curability of the disease by RIC. However, we have also observed that the patterns of post-RIC changes in HTLV-1 proviral load over time among the 10 survivors were classified into three patterns. This is the first report to clarify the long-term outcomes after RIC for ATLL patients.

Entities:  

Mesh：

Year:  2010        PMID： 20400987     DOI： 10.1038/bmt.2010.92

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


  27 in total

1.  Administration of an anti-CC chemokine receptor 4 monoclonal antibody, mogamulizumab, before allogeneic bone marrow transplantation for adult T-cell leukemia/lymphoma.

Authors:  S Haji; J Kiyasu; I Choi; Y Suehiro; K Toyoda; M Tsuda; A Takamatsu; Y Nakashima; H Miyoshi; M Shiratsuchi; S Yamasaki; N Uike; Y Abe
Journal:  Bone Marrow Transplant       Date:  2015-11-02       Impact factor: 5.483

2.  Characteristic patterns of relapse after allogeneic hematopoietic SCT for adult T-cell leukemia-lymphoma: a comparative study of recurrent lesions after transplantation and chemotherapy by the Nagasaki Transplant Group.

Authors:  H Itonaga; Y Sawayama; J Taguchi; S Honda; H Taniguchi; J Makiyama; E Matsuo; S Sato; K Ando; D Imanishi; Y Imaizumi; S Yoshida; T Hata; Y Moriuchi; T Fukushima; Y Miyazaki
Journal:  Bone Marrow Transplant       Date:  2015-01-26       Impact factor: 5.483

3.  HTLV-I-associated posttransplant lymphoproliferative disorder following virus transmission from recipient to donor cells.

Authors:  Noriaki Kitamura; Tsukasa Nakanishi; Yasuhiro Yoshida; Takehiro Higashi; Junichi Tsukada
Journal:  Blood       Date:  2017-05-09       Impact factor: 22.113

Review 4.  A Review of Autologous Stem Cell Transplantation in Lymphoma.

Authors:  Umar Zahid; Faisal Akbar; Akshay Amaraneni; Muhammad Husnain; Onyee Chan; Irbaz Bin Riaz; Ali McBride; Ahmad Iftikhar; Faiz Anwer
Journal:  Curr Hematol Malig Rep       Date:  2017-06       Impact factor: 3.952

5.  Unrelated cord blood transplantation for patients with adult T-cell leukemia/lymphoma: experience at a single institute.

Authors:  Takayuki Nakamura; Eijiro Oku; Kei Nomura; Satoshi Morishige; Yuka Takata; Ritsuko Seki; Rie Imamura; Koichi Osaki; Michitoshi Hashiguchi; Kazuaki Yakushiji; Fumihiko Mouri; Shinichi Mizuno; Koji Yoshimoto; Koichi Ohshima; Koji Nagafuji; Takashi Okamura
Journal:  Int J Hematol       Date:  2012-09-14       Impact factor: 2.490

6.  Feasibility of cord blood transplantation in chemosensitive adult T-cell leukemia/lymphoma: a retrospective analysis of the Nagasaki Transplantation Network.

Authors:  Takuya Fukushima; Hidehiro Itonaga; Yukiyoshi Moriuchi; Shinichiro Yoshida; Jun Taguchi; Yoshitaka Imaizumi; Daisuke Imanishi; Hideki Tsushima; Yasushi Sawayama; Emi Matsuo; Tomoko Hata; Yasushi Miyazaki
Journal:  Int J Hematol       Date:  2013-03-13       Impact factor: 2.490

7.  Radiation therapy for the management of patients with HTLV-1-associated adult T-cell leukemia/lymphoma.

Authors:  Charles B Simone; John C Morris; Donn M Stewart; Nicole E Urquhart; John E Janik; Robert J Kreitman; Elena Lita; Kevin Conlon; Gilian Wharfe; Thomas A Waldmann; Aradhana Kaushal
Journal:  Blood       Date:  2012-06-22       Impact factor: 22.113

Review 8.  Treatment advances and prognosis for patients with adult T-cell leukemia-lymphoma.

Authors:  Hiroo Katsuya; Kenji Ishitsuka
Journal:  J Clin Exp Hematop       Date:  2017-06-08

9.  Increased incidence of adult T cell leukemia-lymphoma and peripheral T cell lymphoma-not otherwise specified with limited improvement in overall survival: a retrospective analysis using data from the population-based Osaka Cancer Registry.

Authors:  Shigeo Fuji; Shuhei Kida; Kayo Nakata; Toshitaka Morishima; Isao Miyashiro; Jun Ishikawa
Journal:  Ann Hematol       Date:  2020-10-21       Impact factor: 3.673

Review 10.  Striving to cure adult T-cell leukaemia/lymphoma: a role for allogeneic stem cell transplant?

Authors:  E H Phillips; A Hodson; O Hermine; A Bazarbachi; K Cwynarski
Journal:  Bone Marrow Transplant       Date:  2016-09-12       Impact factor: 5.483
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.